4 курс / Дерматовенерология / ПРЕПАРАТЫ_БОТУЛИНИЧЕСКОГО_ТОКСИНА_ЧТО_МЫ_ИМЕЕМ_И_ЧТО_ВИДИМ_НА_ГОРИЗОНТЕ

ботулинического токсина типа А в жидкой форме у пациентов с мимическими морщинами и блефароспазмом. Клиническая дерматология и венерология. 2020;2:243-249.

Bakulev AL, Galustyan AN, Nezabudkina AS, Ryndyuk NN. Investigation of safety, tolerability and effectiveness of botulinum toxin type a in liquid form in patients with facial wrinkles and blepharospasm. Klinicheskaya dermatologiya i venerologiya. 2020;2:243-249. (In Russ.). https://doi.org/10.17116/klinderma202019021250

85.Glogau R, Blitzer A, Brandt F, Kane M, Monheit GD, Waugh JM. Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of mod- erate-to-severe lateral canthal lines. J Drugs Dermatol. 2012;11(1):38-45.

86.Glogau RG. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehiclecontrolled study. Dermatol Surg. 2007;33(1 Spec No.):76-80. https://doi.org/10.1111/j.1524-4725.2006.32335.x

87.Fonfria E, Maignel J, Lezmi S, et al. The Expanding Therapeutic Utility of Botulinum Neurotoxins. Toxins (Basel). 2018;10(5):208. https://doi.org/10.3390/toxins10050208

88.Lueangarun S, Sermsilp C, Tempark T. Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study. Dermatol Surg. 2018; 44(8):1094-1101.

https://doi.org/10.1097/DSS.0000000000001532

89.Carmichael NM, Dostrovsky JO, Charlton MP. Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain. 2010;149(2):316-324. https://doi.org/10.1016/j.pain.2010.02.024.

90.Zhang EZ, Tan S, Loh I. Botolinum toxin in rhinitis: Literature review and posterior nasal injection in allergic rhinitis. Laryngoscope. 2017;127(11):24472454.

https://doi.org/10.1002/lary.26616

91.Rohrbach S, Junghans K, Köhler S, Laskawi R. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. Head Face Med. 2009;5:18. Published 2009 Oct 16. https://doi.org/10.1186/1746-160X-5-18

92.Ozcan C, Ismi O. Botulinum Toxin for Rhinitis. Curr Allergy Asthma Rep. 2016;16(8):58.

https://doi.org/10.1007/s11882-016-0636-3

Поступила 10.04.20

Received 10.04.20

Принята в печать 13.05.20

Accepted 13.05.20